# clm_2CFC5ECC25A5

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_assets  
value: 17,772,200,000 United States dollar  
valid_from: 2021-03-31  
valid_to: 2021-06-30  
published: 2021-05-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_17B10E4A6B92  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total assets: 17,772,200,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_2CFC5ECC25A5, https://asof.is/claim/clm_2CFC5ECC25A5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000017/0001804220-21-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2021, published 2021-05-06)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 17,163,300,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_2CFC5ECC25A5](/claim/clm_2CFC5ECC25A5.md) | [clm_6964829D3216](/claim/clm_6964829D3216.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.